RSS Feeds
Search

Press releases

Press releases

Displaying 1..1 of 1 - per page
Order by
InNexus Biotechnology, Inc. and Affimed Therapeutics AG today announced a collaboration utilizing Affimed's antibodies and InNexus' SuperAntibody antibody enhancement drug development platform. More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us